|
Dispatch Trichinella pseudospiralis Outbreak in FranceStéphane Ranque,* Bernard Faugère,*† Edoardo Pozio,† Giuseppe La Rosa,† Alessandra
Tamburrini,† Jean-François Pellissier,‡ and Philippe Brouqui*
Until 1995, Trichinella pseudospiralis, a nonencapsulating species of the genus Trichinella and the only species that infects both mammals and birds, was not considered a potential pathogen of humans and domestic animals, since it had been detected only in sylvatic animals (raccoon dog, corsac fox, tiger cat, tawny eagle, and rook) in remote regions (Caucasus, Kazakhstan, Tasmania) (1). However, this pathogen has since been detected in wildlife in the United States (2), in domestic and synanthropic animals and humans in Russia (3), and in humans in Thailand (4). In October 1999, a human outbreak of trichinellosis in France was traced to infected wild boar meat. We describe the epidemiologic, clinical, and laboratory investigations that confirmed T. pseudospiralis as the etiologic agent. The StudyIn October 1999, four adults living in Miramas, a small town in southeastern France, sought medical attention for asthenia, fever, nausea, and watery diarrhea. Three of the patients were members of the same household (father, mother, and son); the fourth was a friend. Their family physicians prescribed symptomatic therapy for gastroenteritis, but their conditions worsened and they were referred to the Infectious and Tropical Diseases Unit of a teaching hospital in Marseille. In initial interviews, all four patients said that they had eaten undercooked barbecued wild boar (Sus scrofa) meat on October 7. The father and his friend hunted the boar in Camargue, a swampy region in the Rhone River Delta. Frozen wild boar meat was thawed, artificially digested, and washed (5) to obtain Trichinella larvae from muscle tissue for examination. Individual larvae were suspended in 5 µl water and stored at -30°C. Larvae were identified by polymerase chain reaction (PCR) analysis in which 10 µl 0.1 M Tris-HCL, pH 7.6, was added to the larvae, overlaid with mineral oil, and heated at 90°C for 10 minutes. PCR was done with Taq DNA polymerase, 10X PCR buffer, and dNTPs (Takara, Otsu, Shiga, Japan). The 30-µl PCR cocktail contained 10X PCR buffer at a final concentration of 1.5 mM MgCL2, 200 mM dNTPs, 50 pmoles of each primer, and 0.5 unit Taq DNA polymerase. For amplification, 2 µl of a single larva preparation was used. Amplifications consisted of 35 cycles as follows: denaturation at 94°C for 20 seconds, annealing at 58°C for 1 minute, and elongation at 72°C for 1 minute. The primer set oTsr1 (5'-CGA AAA CAT ACG ACA ACT GC-3') and oTsr4 (5'-GTT CCA TGT GAA CAG CAG T-3') amplifies a region in the LSU-RNA known as the expansion segment V (ESV) (6). Larvae from reference strains of T. spiralis (code ISS3), T. pseudospiralis (code ISS13), and T. britovi (code ISS2) were used as controls. Crude and excretory-secretory Trichinella antigens were prepared from larvae for enzyme-linked immunosorbent assay (ELISA) and immunoblotting (7). An indirect ELISA was used to detect parasite-specific immunoglobulin (Ig) G in human serum samples (8). Briefly, antigens were used at a concentration of 5 µg/ml in 0.1 M carbonate-bicarbonate buffer, pH 9.6. Serum samples were studied at several dilutions (range 1:200 to 1:6,400), and the conjugate (Bio-Rad, Hercules, CA) was at 1:10,000 dilution. Electrophoresis of crude and excretory-secretory antigens from T. spiralis, T. pseudospiralis, and T. britovi was done with 10% SDS-polyacrylamide gels under reducing conditions. Proteins were transferred to nitrocellulose and incubated with human sera diluted 1:100. Serum samples from five persons with confirmed trichinellosis and five known to be Trichinella free were used as positive and negative controls. The incubation period for the hunters (patients 2 and 4), who both ate >300 g of boar meat, was half as long, and their clinical symptoms (fever and myalgias) lasted twice as long as those of the other two patients, who ate <300 g. Other clinical and laboratory abnormalities were not correlated with the estimated size of the inoculum. Diarrhea was the initial symptom for all patients (Table). When the patients were hospitalized on October 31, they had fever, asthenia, and myalgias (torn muscle pain worsened by exertion); none had vomiting or rash. The patients were treated with albendazole (800 mg/day) for 10 days combined with prednisone (30 mg/kg/day) for the first 3 days. The asthenia and myalgias initially worsened but then gradually improved, and all four patients recovered completely within 4 months. All patients had elevated peripheral blood eosinophil counts (1.6 to 5.3 x109/L) and decreased plasma albumin levels. Serum creatine phosphokinase concentrations were elevated, with peak levels of 286 to 8,389 U/L (Table).
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ConclusionsThis is the first report of human T. pseudospiralis infection in Europe. The first reported human case was detected in New Zealand, but the infection was probably acquired in Tasmania (9). This is only the third reported human T. pseudospiralis outbreak in the world. The first, in Thailand, affected 59 persons; one died (4). The second, in Kamchatka, Russia, affected approximately 30 persons (3). The clinical findings in our patients are consistent with previous reports of uncomplicated T. pseudospiralis (4) and T. spiralis infections (10). None of our patients had the life-threatening cardiopulmonary, renal, and central nervous system complications typical of trichinellosis infection. However, our patients had two unusual clinical features: fever persisted 13 to 29 days, considerably longer than previously reported for patients infected with T. pseudospiralis (4) or T. spiralis (10); and all four patients recovered completely within 4 months, in contrast with previous reports of severe asthenia and myalgias persisting for longer periods (4,11). Our patients received early treatment with effective anthelminthics and responded rapidly, which may explain the shorter duration of clinical symptoms. The laboratory findings in our four patients are consistent with those reported in trichinellosis; however, low plasma albumin and elevated triglyceride levels have not been reported in earlier outbreaks. The results of the Western blot analysis of sera from our patients demonstrated that immunoblotting cannot be used to identify the etiologic agent on the basis of recognized antigens. These findings contrast with those of a previous report (11) of an unusual Western blot pattern in serum samples from a patient thought to be infected only with T. pseudospiralis. However, subsequent investigation showed that this patient was also infected with another tissue nematode (Haycocknema perplexum)(12,13). In Europe, T. pseudospiralis has been detected in a raccoon dog in the Krasnodar region of Caucasus (14), in two night birds of prey in central Italy (15), and recently in four raccoon dogs, one wild boar, and one brown rat in Finland (1). Although T. pseudospiralis can be considered a sylvatic genotype, the recent finding of this parasite in domestic pigs and brown rats on a farm in Kamchatka (3) suggests that, in certain epidemiologic situations, this parasite is transmitted to the human environment and should be considered a new potential parasite for domestic pigs. Pigs raised on ecologic (organic) farms are more likely to feed on infected wild animal carcasses than those raised on industrialized farms (16). These epidemiologic data suggest that either the prevalence of T. pseudospiralis infection is increasing in sylvatic and domestic animals of Europe and other continents or that techniques for diagnosing human and animal infections have improved, allowing identification of this nonencapsulated Trichinella species. Trichinelloscopy (visualizing Trichinella larvae by transillumination of small pieces of muscle from the diaphragm pillars between two thick slides) is used for trichinellosis screening in slaughterhouses. Because the collagen capsule is lacking, T. pseudospiralis larvae can easily be mistaken for muscle fiber. Therefore, trichinelloscopy is ineffective for screening in slaughterhouses or for diagnosis of human biopsy specimens. The finding that all larvae detected after artificial digestion of frozen meat were dead suggests that freezing may make game meat safe from T. pseudospiralis infection. Experimental infection of domestic pigs and wild boars with T. pseudospiralis (17,18) showed that these hosts can harbor a substantial number of T. pseudospiralis larvae up to 20 weeks, but most muscle larvae had disappeared by 40 weeks after infection. However, several factors can contribute to the infectivity and persistence of this parasite species in domestic and sylvatic swine: the genetic variability of T. pseudospiralis isolates (6); the genetic variability of pigs and wild boars; and the occurrence in nature of stress, starvation, or concomitant infections that can induce immunosuppression in wild boars. Twelve cases of trichinellosis associated with eating wild boar meat were reported from June 1994 to December 1995, in southeastern France, clustered around seven geographic foci (19). Some of these cases may have been caused by T. pseudospiralis, since neither histology of muscle biopsy nor recently developed molecular typing methods were used to verify the specific diagnosis. Molecular typing has opened new avenues for scientific investigations of trichinellosis and promises better understanding of the emerging pathogen that causes it. The broad spectrum of T. pseudospiralis hosts (both mammals and birds), the difficulty in detecting this parasite by trichinelloscopy, the potentially severe clinical picture in humans, and the increasing occurrence of this parasite indicate that expanded surveillance is needed to monitor the introduction and spread of trichinellosis. AcknowledgmentsThe authors thank J. Bakken for English review of the manuscript, M. Niang and S. Badiaga for their assistance, and J. Delmont for helpful comments. Dr. Ranque is a specialist in infectious and tropical diseases at University Hospital in Marseille, France. His research focuses on the human host's genetic susceptibility to infectious diseases. Address for correspondence: Philippe Brouqui, Faculté de Médecine, 27 Boulevard Jean Moulin, F-13385 Marseille cedex 5, France; fax: 33-4-9183-0390; e-mail: Philippe.Brouqui@medecine.univ-mrs.fr References
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Home | Top of Page | Current Issue | Expedited | Upcoming Issue | Past Issue | EID Search | Contact Us CDC Home | Search | Health Topics A-Z This page last reviewed July 31, 2000 Emerging Infectious Diseases Journal |